期刊文献+

乌司他丁对脓毒性休克婴幼儿白介素-1、肿瘤坏死因子α及降钙素原的影响 被引量:1

Effects of Ulinastatin on Interleukin-1,Tumor Necrosis Factor-α and Procalcitonin Levels in Infants with Septic Shock
下载PDF
导出
摘要 目的探讨乌司他丁对脓毒性休克婴幼儿白介素-1(IL-1)、肿瘤坏死因子α(TNF-α)及降钙素原(PCT)的影响。方法将60例脓毒性休克患儿按随机数字表法分为对照组和治疗组,每组30例。对照组给予抗休克和病因治疗,治疗组在对照组治疗的基础上,给予乌司他丁2万U·kg-1加入5%葡萄糖注射液50 mL中静脉滴注,q8h。2组均5 d为1个疗程。2组患儿分别于入住ICU时及治疗5 d后采集静脉血4 mL,测定TNF-α、IL-1及PCT,观察治疗前后TNF-α、IL-1及PCT水平的变化。结果 2组治疗前IL-1、TNF-α和PCT水平的变化比较差异均无统计学意义(均P>0.05);治疗组治疗5 d后IL-1、TNF-α和PCT分别为(86.48±17.29)pg·L-1、(105.86±20.79)pg·L-1和(5.33±0.85)ng·mL-1,对照组治疗5 d后IL-1、TNF-α和PCT分别为(112.34±18.54)pg·L-1、(189.04±28.36)pg·L-1和(8.54±1.43)ng·mL-1,治疗组明显低于对照组(均P<0.05)。结论乌司他丁对脓毒性休克婴幼儿IL-1、TNF-α及PCT有明显降低作用,从而能改善患儿的预后。 Objective To investigate the effects of ulinastatin on the levels of interleukin-1(IL-1), tumor necrosis factor-α(TNF-α) and procalcitonin(PCT) in infants with septic shock. Methods Sixty infants with septic shock were randomly divided into two groups,with 30 infants in each group. The control group was given anti-shock and etiological treatment. On this basis,the treatment group was given intravenous drip of ulinastatin (20 000 U·kg-1 in 50 mL of 5% glucose solution, once every 8 hours).The course of treatment was 5 days.Venous blood samples(4 mL)were taken after ICU admission and treatment for 5 days to determine the levels of IL-1,TNF-α and PCT in both groups. Results There were no significant differences in the levels of IL-1,TNF-α and PCT between the two groups before treatment(P〉0.05). Compared with control group,the levels of IL-1,TNF-αand PCT significantly decreased in treatment group after treatment for 5 days [(86.48±17.29)pg·L-1 vs(112.34±18.54)pg·L-1, (105.86±20.79)pg·L-1 vs (189.04±28.36)pg·L-1 and (5.33±0.85)ng·mL-1 vs (8.54±1.43)ng·mL-1, respectively; P&lt;0.05]. Conclusions Ulinastatin treatment can reduce the levels of IL-1, TNF-α and PCT and improve the prognosis in infants with septic shock.
出处 《实用临床医学(江西)》 CAS 2014年第4期8-9,13,共3页 Practical Clinical Medicine
关键词 乌司他丁 婴幼儿 脓毒性休克 白介素-1 肿瘤坏死因子Α 降钙素 ulinastatin infants septic shock interleukin-1 tumor necrosis factor-α procalcitonin
  • 相关文献

参考文献8

  • 1甘晓庄.全国PICU 脓毒症调查的多中心临床研究[J]中国小儿急救医学,2010(会议专辑):67.
  • 2张在其;黄子通.急危重病临床救治[M]武汉:湖北科学技术出版社,2010611.
  • 3Karlsson S,Heikkinen M,Pettila V. Predictive value of procalcitonin decrease in patients with severe sepsis:a prospective observational study[J].CRITICAL CARE,2010,(06):R205.
  • 4Park W Y,Goodman R B,Steinberg K P. Cytokine balance in the lungs of patients with acute respiratory distress syndrome[J].American Journal of Respiratory and Critical Care Medicine,2001,(10 Pt 1):1896-1903.
  • 5中华医学会儿科学分会急救学组;中华医学会急诊学分会儿科组.儿科感染性休克(脓毒性休克)诊疗推荐方案[J]中华儿科杂志,2006(04):313-314.
  • 6姚咏明,盛志勇,林洪远,柴家科.脓毒症定义及诊断的新认识[J].中国危重病急救医学,2004,16(6):321-324. 被引量:307
  • 7刘岚,郑玉强,景春梅,谢伟,李春莉.儿童全身炎症反应综合征内毒素水平与IL-6、IL-10、TNF-α及PCT的动态监测[J].中国抗生素杂志,2008,33(5):297-299. 被引量:8
  • 8景炳文.乌司他丁在急危重症临床应用的进展[J].中国危重病急救医学,2006,18(2):117-120. 被引量:127

二级参考文献47

共引文献437

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部